You are here

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Correction
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Authors

  • Kellie N. Smith Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Nicolas J. Llosa Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Tricia R. Cottrell Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA Department of PathologyJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Nicholas Siegel Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Hongni Fan Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Prerna Suri Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Hok Yee Chan Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Haidan Guo Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Teniola Oke Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Anas H. Awan Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Franco Verde Russell H. Morgan Department of Radiology and Radiological ScienceJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Ludmila Danilova Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA Division of Biostatistics and BioinformaticsJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Valsamo Anagnostou Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Ada J. Tam Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Brandon S. Luber Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Division of Biostatistics and BioinformaticsJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Bjarne R. Bartlett Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA The Swim Across America LaboratoryJohn Hopkins University Baltimore MD USA Ludwig Center and Howard Hughes Medical Institute, Johns Hopkins University Baltimore MD USA Present address: B.R.B., Bioinformatics Core, Department of Complementary & Integrative MedicineUniversity of Hawaii John A. Burns School of Medicine 96813 Honolulu HI USA PubMed articlesGoogle scholar articles
  • Laveet K. Aulakh Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA The Swim Across America LaboratoryJohn Hopkins University Baltimore MD USA Ludwig Center and Howard Hughes Medical Institute, Johns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • John-William Sidhom Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Qingfeng Zhu Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA Department of PathologyJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Cynthia L. Sears Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Leslie Cope Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA Division of Biostatistics and BioinformaticsJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • William H. Sharfman Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Elizabeth D. Thompson Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA The Swim Across America LaboratoryJohn Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Joanne Riemer Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Kristen A. Marrone Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Jarushka Naidoo Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Victor E. Velculescu Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Patrick M. Forde Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Bert Vogelstein Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Ludwig Center and Howard Hughes Medical Institute, Johns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Kenneth W. Kinzler Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Ludwig Center and Howard Hughes Medical Institute, Johns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Nickolas Papadopoulos Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Ludwig Center and Howard Hughes Medical Institute, Johns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Jennifer N. Durham Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Hao Wang Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA Division of Biostatistics and BioinformaticsJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Dung T. Le Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Sune Justesen Immunitrack Copenhagen Denmark PubMed articlesGoogle scholar articles
  • Janis M. Taube Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA Department of PathologyJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Luis A. Diaz Jr Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA The Swim Across America LaboratoryJohn Hopkins University Baltimore MD USA Ludwig Center and Howard Hughes Medical Institute, Johns Hopkins University Baltimore MD USA Department of Medicine, Division of Solid Tumor OncologyMemorial Sloan Kettering Cancer Center New York NY USA PubMed articlesGoogle scholar articles
  • Julie R. Brahmer Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Drew M. Pardoll Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Robert A. Anders Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA Department of PathologyJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  • Franck Housseau Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University Baltimore MD USA Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University Baltimore MD USA PubMed articlesGoogle scholar articles
  1. ↵‰ fhousse1{at}jhmi.edu
View Full Text

Citation

Smith KN, Llosa NJ, Cottrell TR, et al
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
Journal for ImmunoTherapy of Cancer 2019;7:63. doi: 10.1186/s40425-019-0547-7

Publication history

  • Received February 26, 2019
  • Accepted February 26, 2019
  • First published March 6, 2019.
Online issue publication 
March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.